back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-05-14 10:24 Tx date 2019-04-26 |
$RX
BioSyent Inc. |
D'Souza, Alfred
4 - Director of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-300,000
-40,000 vol $7.50 each |
1,386,300 | |
| Filed 2019-02-03 Tx date 2019-01-30 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-190,021
-23,500 vol $8.09 each |
1,426,300 | |
| Filed 2019-01-21 Tx date 2019-01-15 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-212,000
-26,500 vol $8.00 each |
1,449,800 | |
| Filed 2018-11-15 Tx date 2018-11-12 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-12,985
-1,400 vol $9.28 each |
1,476,300 | |
| Filed 2018-11-03 Tx date 2018-11-02 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-130,690
-14,000 vol $9.34 each |
1,477,700 | |
| Filed 2018-11-03 Tx date 2018-10-29 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,545
-700 vol $9.35 each |
1,491,700 | |
| Filed 2018-09-19 Tx date 2018-09-07 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-133,700
-14,000 vol $9.55 each |
1,492,400 | |
| Filed 2018-09-01 Tx date 2018-08-27 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-462,500
-50,000 vol $9.25 each |
1,506,400 | |
| Filed 2018-07-01 Tx date 2018-06-29 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,636
-700 vol $9.48 each |
1,556,400 | |
| Filed 2018-07-01 Tx date 2018-06-25 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-95,000
-10,000 vol $9.50 each |
1,557,100 | |
| Filed 2018-06-19 Tx date 2018-06-13 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-14,685
-3,300 vol $4.45 each |
14,627 | |
| Filed 2018-06-19 Tx date 2018-06-13 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$14,685
+3,300 vol $4.45 each |
5,671 | |
| Filed 2018-06-19 Tx date 2018-06-13 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-33,000
-3,300 vol $10.00 each |
2,371 | |
| Filed 2018-06-19 Tx date 2018-06-13 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-29,610
-3,000 vol $9.87 each |
1,568,900 | |
| Filed 2018-06-19 Tx date 2018-06-15 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,745
-1,700 vol $9.85 each |
1,567,200 | |
| Filed 2018-06-19 Tx date 2018-06-18 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-982.00
-100 vol $9.82 each |
1,567,100 | |
| Filed 2018-06-12 Tx date 2018-06-08 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,060
-2,000 vol $10.03 each |
1,571,900 | |
| Filed 2018-06-12 Tx date 2018-06-06 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,105
-2,100 vol $10.05 each |
1,573,900 | |
| Filed 2018-03-28 Tx date 2017-12-31 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$21,244
+2,371 vol $8.96 each |
2,371 | |
| Filed 2018-01-15 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$38,419
+4,002 vol $9.60 each |
17,927 | |
| Filed 2017-09-26 Tx date 2017-09-22 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-55,510
-6,100 vol $9.10 each |
1,576,000 | |
| Filed 2017-09-26 Tx date 2017-09-21 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
51 - Exercise of options
|
$5,551
+6,100 vol $0.91 each |
1,582,100 | |
| Filed 2017-09-26 Tx date 2017-09-21 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-5,551
-6,100 vol $0.91 each |
13,925 | |
| Filed 2017-04-04 Tx date 2017-03-30 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-38,000
-5,000 vol $7.60 each |
1,577,800 | |
| Filed 2017-04-04 Tx date 2017-03-31 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,950
-1,800 vol $7.75 each |
||
| Filed 2017-04-04 Tx date 2017-03-31 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,950
-1,800 vol $7.75 each |
1,576,000 | |
| Filed 2017-03-15 Tx date 2017-03-14 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$34,596
+4,707 vol $7.35 each |
20,025 | |
| Filed 2016-03-29 Tx date 2016-03-24 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,591
+3,100 vol $6.96 each |
1,580,800 | |
| Filed 2016-03-29 Tx date 2016-03-29 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,014
+2,000 vol $7.01 each |
1,582,800 | |
| Filed 2016-02-17 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$23,857
+3,848 vol $6.20 each |
15,318 | |
| Filed 2015-06-27 Tx date 2015-06-23 |
$RX
BioSyent Inc. |
D'Souza, Alfred
5 - Senior Officer of Issuer
Holder: RBC Direct Investing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,200
-2,000 vol $8.10 each |
1,577,700 |